Mod B - Week 1 Final

Front 1

What info should you find on the mfgs label of a med?

Back 1

Trade name, generic name, dosage strength, dosage form, qty supplied, directions, rdc, mfg, exp date & lot number.

Front 2

In which form may a prescription arrive to the pharmacy?

Back 2

Carried in by patient, fax, computer generated & phoned in by physician.

Front 3

What info is found on the upper part of a written prescription?

Back 3

Patient's full name, date of issue of the RX, the name and title of prescriber, DEA number.

Front 4

What info is found on the body of a written prescription?

Back 4

The name of the drug prescribed, strength and dosage form, qty, instructions for dosage, & labeling, signature of the prescriber in ink, authorization to dispense a generic substitution and refill info.

Front 5

What info should be gathered at the time the RX is left?

Back 5

Patient's address and telephone number, age, date of birth of patient, allergies and insurance coverage of the patient.

Front 6

What should you do if a patient funs out of refills?

Back 6

If a patient runs out of refills, the pharmacy may contact the physician for authorization.

Front 7

When are "easy open" caps ok to be used?

Back 7

When a patient signs a waiver.

Front 8

What is the rule of thumb when filling an RX?

Back 8

The bottle should be 2/3 full.

Front 9

When should the brand name be printed on an RX label?

Back 9

If the RX was for a name brand drug and the generic was dispensed, both names should be on the label.

Front 10

When should the technician initial the label? Why?

Back 10

After they are done properly labeling the container. So the pharmacist knows who to talk to if there is a mistake found.

Front 11

What is the purpose of an auxiliary label?

Back 11

To remind the patient of the best way to use the drug for: maximum effect and things to avoid.

Front 12

Define adverse drug reactions

Back 12

Any unexpected obvious changes in a patients conditions that a physician suspects may be due to a drug

Front 13

Define the classes of recalls

Back 13

Class 1-reasonable probability that the use or exposure to a violative product will cause severe adverse health consequences.
Class II-the use or exposure to a violative product may cause temporary or medically reversible adverse health consequences.
Class III-the use or exposure to a violative product is not likely to cause adverse health consequences.

Front 14

Summarize the steps of an investigational drug

Back 14

Pre clinical: drug can only be given to animals.
Clinical studies
Phase I - the first time a new drug is introduced into humans.
Phase II - establishing the activity of the new drug in actual clinical situations.
Phase III - establish the acceptable use of the drug.